Home
FSHP vs CTOR Comparison

FSHP vs CTOR Comparison

Compare FSHP & CTOR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FSHP

CTOR

Machine Learning Prediction

ML Decision
FSHP
CTOR

Stock Information

Founded
FSHP 2018
CTOR 2021

Country
FSHP United States
CTOR United States

Employees
FSHP N/A
CTOR N/A

Industry
FSHP
CTOR

Sector
FSHP
CTOR

Exchange
FSHP NYSE
CTOR NYSE

Market Cap
FSHP 90.8M
CTOR 89.9M

IPO Year
FSHP 2024
CTOR N/A

Fundamental

Price
FSHP $10.23
CTOR $1.23

Analyst Decision
FSHP
CTOR Strong Buy

Analyst Count
FSHP 0
CTOR 2

Target Price
FSHP N/A
CTOR $4.50

AVG Volume (30 Days)
FSHP 7.5K
CTOR 78.9K

Earning Date
FSHP 01-01-0001
CTOR 02-21-2025

Dividend Yield
FSHP N/A
CTOR N/A

EPS Growth
FSHP N/A
CTOR N/A

EPS
FSHP 0.11
CTOR N/A

Revenue
FSHP N/A
CTOR N/A

Revenue This Year
FSHP N/A
CTOR N/A

Revenue Next Year
FSHP N/A
CTOR N/A

P/E Ratio
FSHP $90.08
CTOR N/A

Revenue Growth
FSHP N/A
CTOR N/A

52 Week Low
FSHP $9.99
CTOR $0.85

52 Week High
FSHP $10.25
CTOR $49.00

Technical

Relative Strength Index (RSI)
FSHP N/A
CTOR N/A

Support Level
FSHP N/A
CTOR N/A

Resistance Level
FSHP N/A
CTOR N/A

Average True Range (ATR)
FSHP 0.00
CTOR 0.00

MACD
FSHP 0.00
CTOR 0.00

Stochastic Oscillator
FSHP 0.00
CTOR 0.00

About FSHP FLAG SHIP ACQUISITION CORPORATION

Flag Ship Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses.

About CTOR CITIUS ONCOLOGY INC

Citius Oncology Inc is a specialty pharmaceutical company dedicated to the development and commercialization of critical care products targeting unmet needs with a focus on oncology products. In addition, Citius completed enrollment in its Phase 2b trial of CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids.

Share on Social Networks: